Letters Opening up data at the EMA

Proactive transparency?

BMJ 2011; 342 doi: http://dx.doi.org/10.1136/bmj.d3840 (Published 20 June 2011) Cite this as: BMJ 2011;342:d3840
  1. A Chailleu, member, management board1,
  2. P Foucras, president1
  1. 1Formindep, F 59100 Roubaix, France
  1. a.chailleu{at}formindep.org

Formindep (www.formindep.org) is an independent self funded association of health professionals and citizens that advocates for transparency in medical information and education and freedom from interests other than those of patients. Our experience of the European Medicines Agency’s (EMA) implementation of its transparency policy agrees with Gøtzsche and Jørgensen’s findings.1

Directive 1049/2001/EC,2 which …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial